Imaging single photocatalytic turnovers to improve drug synthesis
Official title: Imaging Single Photocatalytic Turnovers in Photoredox Catalysis for Efficient DrugSynthesis
Funded at University of Akron · NIH-11361187 · Data updated 2026-11-12
A patient-friendly look at a project that aims to understand how light-powered catalysts work one molecule at a time to help make drugs more efficiently.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Akron NIH-funded |
| Lab location | 1 site (Akron, United States) |
| Project start | June 1, 2026 |
| Project end | May 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $554,078 |
| NIH project number | 1R15GM159261-01A1 |
| Project ID | NIH-11361187 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable; this is a chemistry-focused project conducted in a lab.
✕Less likely to help
Patients are not directly enrolled in this study.
What this research studies
This project will study how photoredox catalysts behave at the level of a single molecule, tracking their redox state in real time to uncover how to boost reaction efficiency and drug yields. Researchers will use advanced fluorescence methods to observe photocatalytic turnovers as they happen, which could reveal new ways to optimize pharmaceutical synthesis. The work focuses on fundamental chemistry, with potential downstream benefits for faster, cleaner drug production that could eventually affect patients. While the study involves lab-based experiments, the goal is to translate insights into practical improvements in drug manufacturing processes.
Why it matters
Potential benefit: If successful, the findings could lead to faster and more efficient production of medicines with potentially lower costs.
How similar studies have gone: Similar single-molecule studies have shown that tracking molecular states can reveal mechanisms that improve yield and efficiency.
Where this research is happening
-
University of Akron
Akron, United States Active
Researchers
- Principal investigator: Liu, Chunming — University of Akron
- Study coordinator: Liu, Chunming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.